Received Mar 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
reconstituted with a different diluent; inappropriate dose of vaccine administered; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of wrong solution used in drug reconstitution in a patient who received MMR (Priorix) for prophylaxis. Co-suspect products included mmr vaccine pre-filled syringe device (Priorix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 12-MAR-2025, the patient received Priorix. On an unknown date, the patient started Priorix Pre-Filled Syringe Device. On an unknown date, an unknown time after receiving Priorix and an unknown time after starting Priorix Pre-Filled Syringe Device, the patient experienced wrong solution used in drug reconstitution (Verbatim: reconstituted with a different diluent) and inappropriate dose of vaccine administered (Verbatim: inappropriate dose of vaccine administered). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 13-MAR-2025 The pharmacist called to report Priorix was reconstituted with a different diluent than the one supplied and administered to a pediatric patient. Diluent used was sterile water, which led to Wrong solution used in drug reconstitution and Inappropriate dose of vaccine administered. The Vaccine Administration Facility is the same as Primary Reporter.